MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$2,079,010
EPS
-$0.34
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
-
-
0*
0
General and administrative
1,383,504
1,612,267
1,413,606*
1,443,827
Research and development
2,077,116
2,123,725
2,590,724*
2,729,891
Collaboration credits
1,336,263
1,233,224
2,091,493*
1,658,248
In-process r&d impairment
-
-
4,624,000*
0
Change in fair value of contingent consideration
89,414
7,427
3,910,925*
-1,721,033
Total operating expenses
2,213,771
2,510,195
10,447,762*
794,437
Operating loss
-2,213,771
-2,510,195
-10,447,762*
-794,437
Impairment of intangible assets
-
-
0*
-
Loss on disposal of fixed assets
-
-
0*
-
Interest income
-
-
273,566*
-
Interest expense
-
-
4,990*
-
Interest income, net
146,232
139,338
-
201,822
Other expense, net
-11,471
-47,127
-89,148*
-23,708
Total other income, net
134,761
92,212
179,428*
178,114
Loss before income tax provision
-2,079,010
-2,417,984
-10,268,334*
-616,323
Income tax provision
0
0
647,238*
-643,129
Net loss
-2,079,010
-2,417,984
-10,915,572
26,806
Net loss attributable to common shareholders
-2,079,010
-2,417,984
-
26,806
Net loss attributable to common shareholders
-
-2,417,984
-10,915,572
26,806
Basic EPS
-0.34
-0.58
-2.7
0.01
Diluted EPS
-0.34
-0.58
-2.838
0.01
Basic Average Shares
6,177,679
4,174,802
4,043,531
4,289,853
Diluted Average Shares
6,177,679
4,174,802
3,846,006
4,361,740
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$2,079,010 Net loss-$2,079,010 Interest income, net$146,232 Loss before incometax provision-$2,079,010 Total other income,net$134,761 Other expense, net-$11,471 Operating loss-$2,213,771 Total operatingexpenses$2,213,771 Research and development$2,077,116 General andadministrative$1,383,504

KIORA PHARMACEUTICALS INC (KPHMW)

KIORA PHARMACEUTICALS INC (KPHMW)